O-Desmetiltramadol

Izvor: Wikipedija
Prijeđi na navigaciju Prijeđi na pretragu
O-Desmetiltramadol
(IUPAC) ime
3-[2-(1-Amino-1-metiletil)-1-hidroksicikloheksil]fenol
Klinički podaci
Identifikatori
CAS broj 73986-53-5
ATC kod nije dodeljen
PubChem[1][2] 130829
ChemSpider[3] 115703
ChEMBL[4] CHEMBL1400 DaY
Hemijski podaci
Formula C15H23NO2 
Mol. masa 249,349 g/mol
SMILES eMolekuli & PubHem
Farmakokinetički podaci
Poluvreme eliminacije ~ 9 h
Farmakoinformacioni podaci
Trudnoća ?
Pravni status ? (SAD)
Način primene konvertovani metabolit

O-Desmetiltramadol (O-DT) je opioidni analgetik i glavni aktivni metabolit tramadola.[5]

(+)-O-Desmetiltramadol je najvažniji metabolit tramadola, koji se proizvodi u jetri nakon konzumacije tramadola. Ovaj metabolit je znatno potentniji agonist μ opioidnog receptora nego početno jedinjenje.[6]

Tramadol se demetiliše jetrenim enzimom CYP2D6[7] na isti način kao i kodein, tako da su poput odgovora na kodein, osobe koje imaju manje aktivnu formu CYP2D6 manje responsivne.

Dva enantiomera O-desmetiltramadola pokazuju veoma različite farmakološke profile.[8] Oba, (+) i (-)-O-desmetiltramadol, su neaktivna kao inhibitori preuzimanja serotonina,[9] ali (-)-O-desmetiltramadol zadržava aktivnost kao inhibitor noradrenalinskog preuzimanja[10].

Reference[uredi | uredi kod]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. Sevcik, J; Nieber, K; Driessen, B; Illes, P (1993). „Effects of the central analgesic tramadol and its main metabolite, O-desmethyltramadol, on rat locus coeruleus neurones”. British Journal of Pharmacology 110 (1): 169–76. PMC 2175982. PMID 8220877. 
  6. Dayer, P; Desmeules, J; Collart, L (1997). „Pharmacology of tramadol”. Drugs 53 Suppl 2: 18–24. DOI:10.2165/00003495-199700532-00006. PMID 9190321. 
  7. Borlak, J; Hermann, R; Erb, K; Thum, T (2003). „A rapid and simple CYP2D6 genotyping assay--case study with the analgetic tramadol”. Metabolism: clinical and experimental 52 (11): 1439–43. DOI:10.1016/S0026-0495(03)00256-7. PMID 14624403. 
  8. Garrido, MJ; Valle, M; Campanero, MA; Calvo, R; Trocóniz, IF (2000). „Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats”. The Journal of Pharmacology and Experimental Therapeutics 295 (1): 352–9. PMID 10992001. 
  9. Bamigbade, T. A.; Davidson, C.; Langford, R. M.; Stamford, J. A. (1997). „Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus”. British journal of anaesthesia 79 (3): 352–356. DOI:10.1093/bja/79.3.352. PMID 9389855. 
  10. Driessen, B; Reimann, W; Giertz, H (1993). „Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro”. British Journal of Pharmacology 108 (3): 806–11. PMC 1908052. PMID 8467366. 

Vidi još[uredi | uredi kod]

Spoljašnje veze[uredi | uredi kod]